Clinical trial
Endoscopic Treatment of Gastroesophageal Reflux Disease
NCT05678491 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endoscopic Treatment of Gastroesophageal Reflux Disease
- Lead sponsor
- St. Olavs Hospital
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- August 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastro esophageal reflux disease